Bortezomib therapy in patients with relapsed/refractory acquired thrombotic thrombocytopenic purpura Ahmet Emre Eskazan Review Article 03 September 2016 Pages: 1751 - 1756
The global burden of pulmonary hypertension in sickle cell disease: a systematic review and meta-analysis B. M. MusaN. A. GaladanciM. H. Aliyu Review Article 16 May 2016 Pages: 1757 - 1764
Bone marrow niche in immune thrombocytopenia: a focus on megakaryopoiesis Elaheh KhodadiAli Amin AsnafiNajmaldin Saki Review Article 28 May 2016 Pages: 1765 - 1776
Comparison of cladribine- and fludarabine-based induction chemotherapy in relapsed or refractory acute myeloid leukaemia Hyunkyung ParkJeonghwan YoukYoungil Koh Original Article 19 August 2016 Pages: 1777 - 1786
Baicalein suppresses the proliferation of acute T-lymphoblastic leukemia Jurkat cells by inhibiting the Wnt/β-catenin signaling Xiaoping LiuShengcai LiuShangqin Liu Original Article 10 August 2016 Pages: 1787 - 1793
Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes Yoo Jin LeeSung Woo ParkSang Kyun Sohn Original Article 17 August 2016 Pages: 1795 - 1804
Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q Ekaterina BalaianClaudia SchusterMartin Wermke Original Article 10 August 2016 Pages: 1805 - 1810
Azacitidine-lenalidomide (ViLen) combination yields a high response rate in higher risk myelodysplastic syndromes (MDS)—ViLen-01 protocol Moshe MittelmanKalman Filanovskyfor The Israel Myelodysplastic Syndrome Working Group (MDS-WG) Original Article 22 August 2016 Pages: 1811 - 1818
Circulating Cd34+ cell count differentiates primary myelofibrosis from other Philadelphia-negative myeloproliferative neoplasms: a pragmatic study C. OrvainD. Luque PazF. Genevieve Original Article 01 September 2016 Pages: 1819 - 1823
TERT rs2736100 genotypes are associated with differential risk of myeloproliferative neoplasms in Swedish and Chinese male patient populations Jenny DahlströmTiantian LiuDawei Xu Original Article Open access 25 August 2016 Pages: 1825 - 1832
The predictive value of selected serum microRNAs for acute GVHD by TaqMan MicroRNA arrays Chunyan ZhangNan BaiYa-Ping Tian Original Article 24 August 2016 Pages: 1833 - 1843
Different effects of lansoprazole and rabeprazole on the plasma voriconazole trough levels in allogeneic hematopoietic cell transplant recipients Takeo YasuTakaaki KonumaArinobu Tojo Original Article 18 August 2016 Pages: 1845 - 1851
Evaluation of neutrophil–lymphocyte ratio in patients with early-stage mycosis fungoides Rafet ErenNihan NizamElif Suyanı Original Article 11 August 2016 Pages: 1853 - 1857
Abnormal expression of inflammatory genes in placentas of women with sickle cell anemia and sickle hemoglobin C disease Letícia C. BaptistaMaria Laura CostaMônica Barbosa de Melo Original Article 22 August 2016 Pages: 1859 - 1867
Reticulocyte count is the most important predictor of acute cerebral ischemia and high-risk transcranial Doppler in a newborn cohort of 395 children with sickle cell anemia André Rolim BelisárioRahyssa Rodrigues SalesMarcos Borato Viana Original Article 13 August 2016 Pages: 1869 - 1880
Cyclosporin A for persistent or chronic immune thrombocytopenia in children Anthony P. Y. LiuDaniel K. L. CheukGodfrey C. F. Chan Original Article 15 August 2016 Pages: 1881 - 1886
A whole blood model of thrombocytopenia that controls platelet count and hematocrit R. S. BercovitzM. K. BrennerD. K. Newman Original Article 12 August 2016 Pages: 1887 - 1894
Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia Tae Kon KimMina L. XuAmer M. Zeidan Letter to the Editor 29 July 2016 Pages: 1895 - 1898
Functional acute liver failure after treatment with pegylated asparaginase in a patient with acute lymphoblastic leukemia: potential impact of plasmapheresis Wibke GöpelUlf SchnetzkeSebastian Scholl Letter to the Editor 04 August 2016 Pages: 1899 - 1901
Risk of thrombosis and hemorrhage in patients with polycythemia vera and atrial fibrillation treated with prophylactic oral anticoagulants Ana Sofia de FreitasAlberto Alvarez-Larrán Letter to the Editor 12 August 2016 Pages: 1903 - 1904
A novel calreticulin mutation in a patient with myeloproliferative neoplasm Amy M. HillJohn PetersKathleen M. Murphy Letter to the Editor 19 August 2016 Pages: 1905 - 1907
Acute pancreatitis as a side effect of anagrelide hydrochloride hydrate: a case report Yutaka ShimazuKazuyo Fujimura Letter to the Editor 15 August 2016 Pages: 1909 - 1910
Splenectomy in ITP: we keep removing a healthy functional organ Eduardo AnguitaFrancisco Javier CandelF. Javier Martín-Sánchez Letter to the Editor 31 August 2016 Pages: 1911 - 1912
Pembrolizumab for relapsed anaplastic large cell lymphoma after allogeneic haematopoietic stem cell transplantation: efficacy and safety Thomas S. Y. ChanPek-Lan KhongYok-Lam Kwong Letter to the Editor 30 July 2016 Pages: 1913 - 1915
Pembrolizumab and lenalidomide induced remission in refractory double-hit lymphoma Thomas S. Y. ChanPek-Lan KhongYok-Lam Kwong Letter to the Editor 30 July 2016 Pages: 1917 - 1918
Suspected encephalitis with Candida tropicalis and Fusarium detected by unbiased RNA sequencing M. ChristopeitA. GrundhoffNicole Fischer Letter to the Editor 29 July 2016 Pages: 1919 - 1921
Carfilzomib: a rare cause of posterior reversible encephalopathy syndrome Nurit Katz-AgranovJennifer PadillaSujith V. Cherian Letter to the Editor 01 August 2016 Pages: 1923 - 1924
Clinical presentation of the hemoglobin Youngstown variant in a Chinese family Yumei HuangMan WangRongrong Liu Letter to the Editor 12 August 2016 Pages: 1925 - 1927
Erratum to: Which pamidronate protocol is the best for treating osteoporosis in beta-thalassemia major? Mehrnoush KowsaryanShiva RahimiMasoomeh Mousavi Erratum 26 August 2016 Pages: 1929 - 1929